2007
DOI: 10.1016/j.bmcl.2007.01.016
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of nitroalkenes as nitric oxide donors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
24
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 40 publications
(24 citation statements)
references
References 30 publications
0
24
0
Order By: Relevance
“…Nitrated fatty acids have been shown to be stable in lipophilic environments, but they have been shown to release NO in aqueous solutions . However, compared with other nitrated fatty acids, OA-NO 2 is relatively stable (half-life aq of approximately 2 h) (Gorczynski et al, 2007), and so it was not surprising that the NO scavenger carboxy-PTIO had no effect on 9-OA-NO 2 TRPA1 activation. The capacity of NO itself to activate TRPA1 is not yet clear.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Nitrated fatty acids have been shown to be stable in lipophilic environments, but they have been shown to release NO in aqueous solutions . However, compared with other nitrated fatty acids, OA-NO 2 is relatively stable (half-life aq of approximately 2 h) (Gorczynski et al, 2007), and so it was not surprising that the NO scavenger carboxy-PTIO had no effect on 9-OA-NO 2 TRPA1 activation. The capacity of NO itself to activate TRPA1 is not yet clear.…”
Section: Discussionmentioning
confidence: 99%
“…All other chemicals were purchased from Sigma-Aldrich (St. Louis, MO). Because of the reported instability of 9-OA-NO 2 in aqueous solutions [half-life aq of approximately 2 h (Gorczynski et al, 2007)], 9-OA-NO 2 was dissolved into the appropriate buffer within 5 min of experimental use.…”
Section: Methodsmentioning
confidence: 99%
“…Research in this field has demonstrated that NO 2 -FAs could occur in vivo as free fatty acids, esterified in complex lipids in hydrophobic compartments, and adducted with proteins-the latter two being the most abundant reservoirs (Schopfer et al, 2005a(Schopfer et al, , 2005bTrostchansky and Rubbo, 2008;Rudolph et al, 2009). Among NO 2 -FAs biological properties, the ability to release NO into aqueous environments has been considered a signaling mechanism of NO 2 -FAs as potent NO donors (Schopfer et al, 2005;Gorczynski et al, 2007). Furthermore, NO 2 -FAs predominantly act via posttranslational modification Geisler and Rudolph, 2012) in which the high electronegativity of NO 2 substituents, when bound to an alkenyl carbon of fatty acids, confers an electrophilic nature upon the adjacent carbon and enables a reversible Michael addition reaction with nucleophiles such as protein His and Cys residues by a process termed "nitroalkylation" (Baker et al, 2007).…”
mentioning
confidence: 99%
“…1 Among the main properties of NO 2 -FAs, the ability to mediate different anti-inflammatory effects in animal systems is noteworthy, 2,3 thus being considered important mediators of cell signaling. Due to the chemical structure of NO 2 -FAs, these molecules have different biological properties, including the release of nitric oxide (NO) in aqueous mediums [4][5][6] and an electrophilic capacity allowing a reversible posttranslational modification. 7,8 Regarding the ability to release NO, basically 2 mechanisms of NO generation from NO 2 -FAs have been proposed, including a modified Nef reaction or by a nitroalkene-rearrangement.…”
Section: Introductionmentioning
confidence: 99%
“…7,8 Regarding the ability to release NO, basically 2 mechanisms of NO generation from NO 2 -FAs have been proposed, including a modified Nef reaction or by a nitroalkene-rearrangement. 4,6,9 Otherwise, the b-carbon adjacent to the nitro group (-NO 2 ) has a strong electrophilicity, representing a target for nucleophilic addition and thus generating a covalent bond with NO 2 -FAs by a reaction specifically termed nitroalkylation. In this sense, this electrophilic character allowing NO 2 -FAs to modulate key cellular targets has been widely reported, e.g., by the activation of the peroxisome proliferator-activated receptor (PPAR) or by the inhibition of nuclear factor-kappa B (NF-B).…”
Section: Introductionmentioning
confidence: 99%